Last filing: May 29, 2026.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | Director | Feb 5, 2024 | May 29, 2026 |
| NewAmsterdam Pharma Co N.V. (NAMS) | Director | Jul 19, 2024 | Jan 9, 2026 |
Also a director at
Recent filings
The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jan 7, 2026, NewAmsterdam Pharma Co N.V.: 3,400 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.